Mon panier

Hamster PCSK9 Protein, His Tag

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
PC9-H52E4-50ug
$270.00
PC9-H52E4-1mg (500ug X 2)
$2245.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Synonyms

    PCSK9, FH3, HCHOLA3, LDLCQ1, NARC1, PC9

  • Source

    Hamster PCSK9, His Tag (PC9-H52E4) is expressed from human 293 cells (HEK293). It contains AA Gln 30 - Ser 691 (Accession # G3GTK5).

    Predicted N-terminus: Gln 30

    Request for sequence
  • Molecular Characterization

    PCSK9 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus. This protein undergoes autocatalytic cleavage to release the pro-peptide and mature chain. The pro-peptide and mature chain are associated through non‑covalent interactions and with a calculated MW of 13.9 kDa and 59.0 kDa respectively. The protein migrates as 18 kDa and 65 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Shipping and Storage

    This product is shipped at ambient temperature.

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SDS-PAGE

    PCSK9 SDS-PAGE

    Hamster PCSK9, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

  • Bioactivity-ELISA

     PCSK9 ELISA

    Immobilized Human LDL R, Fc Tag at 5 μg/mL (100 μL/well) can bind Hamster PCSK9, His Tag (Cat. No. PC9-H52E4) with a linear range of 0.078-0.313 μg/mL (QC tested).

    Protocol
  •  PCSK9 ELISA

    Immobilized Hamster PCSK9, His Tag (Cat. No. PC9-H52E4) at 1 μg/mL (100 μL/well) can bind Evolocumab with a linear range of 2-63 ng/mL (Routinely tested).

    Protocol
  • Bioactivity-BLI

     PCSK9 BLI

    Loaded Human LDL R, Fc Tag on Protein A Biosensor, can bind Hamster PCSK9, His Tag (Cat. No. PC9-H52E4) with an affinity constant of 4.09 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

FAQ

  • Product

    What key experimental conditions should be considered for PCSK9–LDLR binding assays?

    It is recommended to perform PCSK9–LDLR binding assays under acidic conditions, as the interaction exhibits higher activity in acidic environments compared to neutral ones. Reference: Effects of pH and Low Density Lipoprotein (LDL) on PCSK9-dependent LDL Receptor Regulation.

Introduction de fond

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is also known as RC1 (neural apoptosis regulated convertase), is a newly identified subtilase belonging to the peptidase S8 subfamily. Mouse PCSK9 is synthesized as a soluble zymogen, and undergoes autocatalytic intramolecular processing in the endoplasmic reticulum, resulting in the cleavage of its propeptide that remains associated with the secreted active enzyme with a broad alkaline pH optimum. This protein plays a major regulatory role in cholesterol homeostasis. PCSK9 binds to the epidermal growth factor-like repeat A (EGF-A) domain of the low-density lipoprotein receptor (LDLR), inducing LDLR degradation. PCSK9 may also have a role in the differentiation of cortical neurons. Mutations in this gene have been associated with a rare form of autosomal dominant familial hypercholesterolemia (HCHOLA3).

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Proprotein convertase subtilisin kexin type 9

  • Catégorie:

  • Nombre de médicaments répertoriés:

    8 Détails

  • Nombre de médicaments cliniques:

    35 Détails

  • Étape de développement la plus élevée:

    Approved

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • FAQ
  • Contexte